Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
PharmaCan Capital Corp. is a Toronto-based merchant bank established to invest in companies involved in the medical marijuana sector in Canada. Founded with a clear focus on the Marihuana for Medical Purposes Regulations (MMPR), the firm has positioned itself as a key player in the burgeoning cannabis industry. The organization has built a diverse portfolio that includes several licensed producers, reflecting its commitment to the sector.
Currently, PharmaCan Capital manages a significant portfolio of investments and has established a reputation for thorough research and due diligence. The firm is headquartered in Toronto, Ontario, and actively engages with companies at various stages of licensing under MMPR. Notable milestones include their substantial equity interests in several leading licensed producers, which underscore their strategic positioning in the market.
PharmaCan Capital focuses exclusively on the medical marijuana sector, investing in companies that are either licensed to produce and sell medical marijuana or are in the process of obtaining such licenses. The firm emphasizes extensive research and due diligence to identify promising investment opportunities. They prioritize partnerships with companies that demonstrate strong management teams and sound business plans, ensuring that their investments are well-founded.
The firm typically engages with companies at various stages of licensing under MMPR, allowing them to support both established producers and emerging applicants. Their investment strategy is characterized by a commitment to understanding the regulatory landscape and the operational challenges faced by companies in the medical marijuana space.
PharmaCan Capital has made significant investments in several notable companies within the medical marijuana sector:
Paul Rosen: President & CEO, brings extensive experience in finance and investment management, having led numerous successful ventures in the cannabis sector.
Glen A. Huber: Vice President, Finance & CFO, has a strong background in financial management and strategic planning, contributing to the firm's financial oversight.
Lorne Gertner: Chairman, a seasoned entrepreneur with a history of successful ventures in the cannabis industry, providing strategic direction to the firm.
Alan Friedman: Director, brings expertise in investment strategy and business development, enhancing the firm's investment approach.
Michael Krestell: Director, has a background in corporate finance and investment analysis, contributing to the firm's due diligence processes.
Steven Isenberg: Director, offers insights from his extensive experience in the healthcare sector, particularly in regulatory compliance and market entry strategies.
To pitch PharmaCan Capital, founders should reach out via email at info@pharmacancapital.com. It is advisable to include a comprehensive business plan and details about the management team in the pitch deck. The firm appreciates clarity and thoroughness in presentations.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, as they can facilitate a more favorable review process.
In recent months, PharmaCan Capital has continued to expand its portfolio in the medical marijuana sector. Notable investments include additional stakes in companies such as Whistler Medical Marijuana Company and Peace Naturals.
The firm has also been actively engaging with new applicants for licenses under MMPR, reflecting its commitment to supporting emerging players in the industry. Updates on their website highlight ongoing developments and strategic partnerships.
What are PharmaCan Capital's investment criteria?
PharmaCan Capital invests in companies that are licensed to produce and sell medical marijuana or are actively seeking such licenses under MMPR. They emphasize strong management teams and sound business plans.
How can I apply or pitch to PharmaCan Capital?
Founders can reach out via email at info@pharmacancapital.com to initiate discussions regarding potential investments. A detailed business plan and information about the management team are recommended.
What makes PharmaCan Capital different from other investors?
PharmaCan Capital's focus on the medical marijuana sector, combined with their extensive research capabilities and established industry connections, allows them to provide valuable insights and support to their portfolio companies.
What is the geographic scope of PharmaCan Capital's investments?
The firm primarily invests in North America, specifically targeting companies within Canada that are involved in the medical marijuana sector.
What is PharmaCan Capital's approach to post-investment involvement?
PharmaCan Capital engages actively with its portfolio companies, providing operational support and guidance to help them navigate the regulatory landscape and achieve their business objectives.
What is the typical check size for PharmaCan Capital?
While specific check sizes are not disclosed, PharmaCan Capital typically invests in companies at various stages of development, reflecting their flexible investment approach.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.